Larson Financial Group’s Day One Biopharmaceuticals DAWN Stock Holding History

Larson Financial Group’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,022	Closed	-$21.9K	–	3812
2026 Q1	$21.9K	Hold	1,022	–	–	﹤0.01%	1790
2025 Q4	$9.53K	Buy	1,022 +1,018	+25,450%	+$8.51K	﹤0.01%	2141
2025 Q3	$28	Buy	+4	New	+$28	﹤0.01%	3383
2025 Q2	–	Sell	-76	Closed	-$603	–	3334
2025 Q1	$603	Buy	+76	New	+$819	﹤0.01%	2525

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Larson Financial Group's DAWN Position: Q2 2026 in Review

Larson Financial Group sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 1,022 shares — an estimated $21.9K sold.

Larson Financial Group first reported a position in DAWN in Q1 2025 and held it in 4 quarters. The position peaked at $21.9K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Larson Financial Group reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Larson Financial Group sold 1,022 Day One Biopharmaceuticals shares in Q2 2026, an estimated $21.9K.
Larson Financial Group first reported a position in Day One Biopharmaceuticals in Q1 2025 and held it in 4 quarters.
Larson Financial Group's Day One Biopharmaceuticals position peaked at $21.9K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.